Hestia Insight Inc. reported its financial results for the nine months ending August 31, 2026, revealing a net loss of $441,239, a significant improvement compared to a net loss of $934,426 during the same period in 2025. The loss from continuing operations was $544,748, which was partially offset by income from discontinued operations amounting to $103,509. The company did not generate any revenue during this period, consistent with the previous year, as it continues to navigate a challenging operational landscape following the divestiture of its only operating subsidiary, Hestia Investments Inc., on July 31, 2026.

Operating expenses for the nine months ended August 31, 2026, totaled $534,461, an increase of $335,907 from $198,554 in the prior year. This rise was primarily attributed to a $500,000 accrued compensation for the CEO, reflecting services rendered over the past six years. Professional fees decreased to $33,848 from $75,416, indicating a reduction in reliance on external service providers as the company streamlined operations during the divestiture process. Other general and administrative expenses surged to $500,613 from $123,138, largely due to the aforementioned compensation accrual.

As of August 31, 2026, Hestia Insight reported total liabilities of $343,703, up from $278,245 at the end of the previous fiscal year. The company had cash and cash equivalents of only $3,852, a sharp decline from $28,871 reported at the end of November 2025. The accumulated deficit increased to $1,499,005, reflecting ongoing financial challenges. The company has no current revenue-generating operations and is exploring funding options through advances from its Chairman, equity financing, or potential mergers and acquisitions.

In terms of operational metrics, Hestia Insight has three employees and relies on independent contractors for additional support. The company is focused on strategic acquisitions and partnerships within the healthcare and biotech sectors to enhance its service offerings. However, the lack of revenue and the significant accumulated deficit raise substantial doubt about its ability to continue as a going concern within the next year. Management has acknowledged the need for additional capital to sustain operations and has indicated that failure to secure such funding could severely impact the company's viability.

Looking ahead, Hestia Insight's management plans to pursue various financing avenues to support its operations and growth strategy. However, the company faces inherent risks and uncertainties, including market conditions and the potential for dilution of existing shareholders if additional equity is issued. The outlook remains cautious as the company navigates its transition following the divestiture and seeks to establish a sustainable operational framework.

About Hestia Insight Inc.

Hestia Insight Inc. is a diversified company providing strategic consulting and capital markets advisory services primarily to healthcare and biotech firms. Its subsidiaries operate in health-focused vending and wellness product industries, including smart vending machines and portable phone charging stations. The company targets small and micro-cap companies, leveraging a global network to accelerate healthcare innovation, development, and commercialization through strategic partnerships, licensing, and acquisitions.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov